-
Not Fee assured
-
Awaiting
verification
Offers
- Face-to-face consultations
- Home chemotherapy
About me
Lloyds Pharmacy Clinical Homecare (LPCH) provides care to more than 85,000 patients in the comfort of their home or in the community every year. All of our services are registered with the Care Quality Commission and are delivered by our highly qualified nurses who are all registered with the Nursing and Midwifery Council.
As a Bupa insured patient having your oncology care provided by LPCH, you’ll receive personalised care from our oncology nurses either in your home or at one of our private out-patient healthcare centres (see the map below for more details). Your care will be supervised and coordinated at all times by the consultant treating you.
Our services have many benefits including:
• 1:1 specialised oncology nursing
• A bespoke treatment plan that suits your needs and availability
• Care delivered in the most convenient setting outside of a hospital
• A clean and safe environment
• Care coordinated with the consultant treating you
• Free parking and a range of amenities, including refreshments and Wi-Fi, at our private out-patient clinics
How it works:
Any Bupa recognised consultant can refer you to have your oncology care provided by LPCH. However the consultant treating you will need to agree that it’s medically appropriate for you to have your care provided by LPCH.
Once the consultant treating you refers you for oncology care provided by LPCH, you’ll be given a dedicated patient care manager. They will supervise your care plan and be there to give you a warm welcome, explain how your care will be delivered and answer any questions you may have.
Your care plan will be divided into cycles, and the number you need will be determined by the consultant treating you. Every cycle will include:
• Having blood taken, at the request of your consultant, normally 48 hours before your next cycle. This can take place at the healthcare centre or at your home depending on where you receive your oncology care.
• A remote consultation with one of our nurses once your blood results have been received.
• Treatment either at home or at our private out-patient healthcare centres
Areas of interest
â— Cancer
â— Homecare
â— Oncology
â— Immunotherapy
â— Chemotherapy
â— Systemic Anti-Cancer Therapy (SACT) Pre-Assessments
â— Mobile Units
â— Sub-cutaneous pharmacy injection clinics
â— Health Centres
â— Community
â— SACT Intervention
â— Lloyds Pharmacy Clinical Homecare (LPCH)
â— Lloyds
Medical secretaries
- LloydsPharmacy Clinical Homecare
- 0345 263 6152
- enquiries@lpclinicalhomecare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
0025B
BH5 PRE COMPOUNDING TEST - (>50)
-
AA999
Oral Chemotherapy Drugs Delivery Costs - (>50)
-
AA997
Infusion Chemotherapy Drugs Delivery Costs - (>50)
-
AA998
Injection Chemotherapy Drugs Delivery Costs - (>50)
-
AD804
abiraterone (Zytiga) - 500mg tablet - (>50)
-
AD988
Pegfilgrastim (Pelmeg) 6mg/0.6ml pre-filled syringe - (>50)
-
AE111
Apalutamide (Erleada) 240mg tabs - (>50)
-
AD935
ribociclib (Kisqali) 200mg tablets x 63 - (>50)
-
AD855
bevacizumab (Aybintio) - 100mg/4ml solution for infusion vials - (>50)
-
AD827
darolutamide (Nubeqa) 300mg tablets - (5-50)
-
AE122
Bevacizumab (Velgezma) 400mg/16ml inj - (5-50)
-
AD798
capecitabine (non-proprietary) - 500mg tablets - (5-50)
-
AD824
fulvestrant (non-proprietary) 250mg/5ml solution for injection pre-filled syringes - (5-50)
-
AD871
Zoledronic acid (Non-proprietary) 4mg/100ml solution for infusion vials - (5-50)
-
AD950
Verzenios (Abemaciclib) 150mg x 28 tablets - (5-50)
-
AD930
Palbociclib (Ibrance) 75mg capsules - (5-50)
-
AE090
Relugolix (Orgovyx) 120mg tab - (5-50)
-
AD949
Verzenios (Abemaciclib) 100mg x 28 tablets - (5-50)
-
AE028
ondansetron (non-proprietary) - 4mg orodispersible tablets - (5-50)
-
AE128
Denosumab (Xgeva) 120mg/mL inj - (5-50)
-
AD948
Verzenios (Abemaciclib) 50mg x 28 tablets - (5-50)
-
AD966
Erleada (apalutamide) 112 x 60mg tablets - (5-50)
-
AD797
capecitabine (non-proprietary) - 150mg tablets - (5-50)
-
AD813
levomepromazine (non proprietary) - 6mg tablets - (5-50)
-
AD990
Ibrutinib (Imbruvica) 280mg tablets - (5-50)
-
AD942
Telotristat Etiprate (Xermelo) 90 x 250mg tablets - (5-50)
-
AE113
Capivasertib 200mg tab - (5-50)
-
AD812
lorlatinib (Lorviqua) - 25mg tablets - (5-50)
-
AD931
palbociclib (Ibrance) 100mg capsules - (5-50)
-
AD933
alectinib (Alecensa) 600mg (4 tablets) - (5-50)
-
AD821
pertuzumab/trastuzumab (Phesgo) 1200mg/600mg/15ml solution for injection vials - (5-50)
-
AE010
nivolumab (Opdivo) 240mg/24ml concentrate for solution for infusion vials - (5-50)
-
AD818
acalabrutinib (Calquence) 100mg capsules - (5-50)
-
AE005
lenalidomide (Revlimid) - 7.5mg capsules - (5-50)
-
AD845
lenalidomide (Revlimid) - 2.5mg capsules - (5-50)
-
H120F
Paclitaxel - (5-50)
-
AD822
bevacizumab (Zirabev) 100mg/4ml solution for infusion vials - (1-5)
-
AD846
osimertinib (Tagrisso) 80mg tablets - (1-5)
-
AD842
cabozantinib (Cabometyx) 40mg tablets - (1-5)
-
AE094
Elacestrant (korserdu) 345mg tablets - (1-5)
-
AD836
trifluridine/tipiracil (Lonsurf) 20mg/8.19mg tablets - (1-5)
-
AD913
Venetoclax (Venclyxto) 112 x 100mg tablets - (1-5)
-
AE051
GEMCITABINE HYDROCHLORIDE (SUN) [1400mg PRE-MADE] Intravenous Infusion 1400 mg in 140ml Solution - (1-5)
-
AD820
pertuzumab/trastuzumab (Phesgo) 600mg/600mg/10ml solution for injection vials - (1-5)
-
AD911
Venetoclax (Venclyxto) 7 x 100mg tablets - (1-5)
-
AD944
Olaparib (Lynparza) 100 MG - (1-5)
-
AE109
Capivasertib 160mg tab - (1-5)